Status:
COMPLETED
A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)
Lead Sponsor:
Eisai Co., Ltd.
Conditions:
Healthy
Eligibility:
MALE
20-40 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the pharmacodynamics/pharmacokinetics of 5 mg, 10 mg, 20 mg and 40 mg of Rabeprazole sodium (E3810) when administered repeatedly once daily for 5 days to health...
Eligibility Criteria
Inclusion
- healthy adult Japanese male between the age of 20-40
- body mass index between 18.5-25
Exclusion
- clinically significant abnormal physical examination, vital signs or electrocardiogram
- use of any prescription medication, antacid, nutritional supplement, vitamin preparation, or herb-containing drug within the previous 4 weeks
- use of any non-prescription medication within the previous 1 week
- history of drug or alcohol abuse
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01202071
Start Date
September 1 2010
End Date
December 1 2010
Last Update
November 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toshima-ku, Tokyo, Japan